Lista de obras - Britta Lundström-Stadelmann

Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.

artículo científico publicado en 2014

Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells

scientific article published on 12 April 2019

Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis

artículo científico publicado en 2018

Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.

artículo científico publicado en 2010

Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.

artículo científico publicado en 2017

Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.

artículo científico publicado en 2009

Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions.

artículo científico publicado en 2010

Editorial overview: From farms and forests to forks? A review of diagnosis and management of globally important zoonotic Echinococcus spp. cestodes

artículo científico publicado en 2019

Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice

artículo científico publicado en 2020

Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.

artículo científico publicado en 2018

Foxp3 T Regulatory Cells as a Potential Target for Immunotherapy against Primary Infection with Echinococcus multilocularis Eggs

artículo científico publicado en 2018

Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.

artículo científico publicado en 2014

In Vitro Efficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes ⬇️

artículo científico publicado el 18 de julio de 2011

In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

artículo científico publicado en 2010

In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives

artículo científico publicado en 2008

In vitro metabolomic footprint of the Echinococcus multilocularis metacestode

artículo científico publicado en 2019

Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.

artículo científico publicado en 2015

Plasmid Vectors for Proteomic Analyses in Giardia: Purification of Virulence Factors and Analysis of the Proteasome ⬇️

artículo científico publicado el 18 de mayo de 2012

Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes

artículo científico publicado en 2014

Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis

artículo científico publicado en 2018

Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis

artículo científico publicado en 2016

Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines.

artículo científico publicado en 2018

The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis

artículo científico publicado en 2019

The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro.

artículo científico publicado en 2013

Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: a novel class of anti-parasitic compounds.

artículo científico publicado en 2008

To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.

artículo científico publicado en 2017

Treatment of echinococcosis: albendazole and mebendazole--what else?

artículo científico publicado en 2014

Lista de obras de Britta Lundström-Stadelmann

Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.

Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells

Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis

Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.

Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.

Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.

Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions.

Editorial overview: From farms and forests to forks? A review of diagnosis and management of globally important zoonotic Echinococcus spp. cestodes

Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice

Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.

Foxp3 T Regulatory Cells as a Potential Target for Immunotherapy against Primary Infection with Echinococcus multilocularis Eggs

Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.

In Vitro Efficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes ⬇️

In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives

In vitro metabolomic footprint of the Echinococcus multilocularis metacestode

Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.

Plasmid Vectors for Proteomic Analyses in Giardia: Purification of Virulence Factors and Analysis of the Proteasome ⬇️

Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes

Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis

Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis

Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines.

The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis

The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro.

Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: a novel class of anti-parasitic compounds.

To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.

Treatment of echinococcosis: albendazole and mebendazole--what else?